Über das Unternehmen
- Firmenname (rechtlich): JEWIM PHARMACEUTICAL(SHANDONG) CO.,LTD.
- Registrierungsland: China
- Adresse: Peitianmen Street, , Tai'an High-Tech Industrial Development Zone, Shandong
- Anzahl der Mitarbeiter: 1000 - 4999
- Gründungsjahr: 1993
Beschreibung:
Founded in 1993, Jewim is an established pharmaceutical company specializing in R&D, production and marketing of innovative and high-end generic drugs, dedicated to treatments for respiratory system diseases that have made it the largest pMDI manufacturer and exporter in China. Today, Jewim's diversified product range covers the respiratory, psychoneural, cardiovascular, skin and mucous membrane therapeutic areas, with a commitment to building a respected and reliable pharmaceutical brand.
Geschäftsaktivitäten
Vertrags- & Outsourcing-Dienstleistungen
HerstellerLohnhersteller (CMO)API-HerstellerRohstofflieferant
Fertigarzneiformen
HerstellerLohnhersteller (CMO)API-HerstellerRohstofflieferant
Arzneimittel-Applikationssysteme
HerstellerLohnhersteller (CMO)API-HerstellerRohstofflieferant
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerLohnhersteller (CMO)API-HerstellerRohstofflieferant
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- South America: Argentina, Bolivia, Brazil, Chile
Hauptprodukte/-dienstleistungen
- Vertrags- & Outsourcing-Dienstleistungen: Oxymetazoline Hydrochloride Nasal Spray, Ipratropium Bromide Ipratropium Nebuliser Solution/ Solution for Inhalation
- Fertigarzneiformen: Salbutamol Sulfate Pressurised Inhalation/Inhaler pMDI, Ipratropium Bromide Pressurised Inhalation/Inhaler pMDI, Beclomethasone Dipropionate Pressurised Inhalation/Inhaler pMDI, Beclometasone Dipropionate and Formoterol Pressurised Inhalation/Inhaler,pMDI, Budesonide Pressurised Inhalation/Inhaler pMDI, Fluticasone Pressurised Inhalation, Oral Dosage Forms, Minoxidil Spray, Spray, Small Volume Parenterals, Metered-dose Inhaler (MDI) Canisters, Oral and topical liquids, Ointments
- Pharmazeutische Chemikalien: Intermediates and APIs
- Arzneimittel-Applikationssysteme: Budesonide and Formoterol Fumarate Inhalation Powder/DPI, Beclometasone Aqueous Nasal Spray
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Zolmitriptan nasal spray
Unsere Produkte & Dienstleistungen
Sell · Drug Delivery Systems
Sell · Finished Dosage Forms
Sell · Finished Dosage Forms
Sell · Finished Dosage Forms
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen